Somatic alterations mostly target a handful of major genes such as CDKN2A, NOTCH1, NRAS, KRAS or TP53, and pathways disrupted by driver alterations are either common to cancer (e.g. cell cycle) or specific to pediatric cancer histotypes4. The gene discussed is KRAS; the disease is cancer.